elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36363866-856F59F9-5E7F-409E-A8AC-49AA87F79630
Q36363866-856F59F9-5E7F-409E-A8AC-49AA87F79630
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36363866-856F59F9-5E7F-409E-A8AC-49AA87F79630
A novel assay for antibody-dependent cell-mediated cytotoxicity against HIV-1- or SIV-infected cells reveals incomplete overlap with antibodies measured by neutralization and binding assays
P2860
Q36363866-856F59F9-5E7F-409E-A8AC-49AA87F79630
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36363866-856F59F9-5E7F-409E-A8AC-49AA87F79630
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fc676d7c99f641cd4a51dfed8ff1b0d523e3de96
P2860
A phase 1/2 comparative vaccine trial of the safety and immunogenicity of a CRF01_AE (subtype E) candidate vaccine: ALVAC-HIV (vCP1521) prime with oligomeric gp160 (92TH023/LAI-DID) or bivalent gp120 (CM235/SF2) boost.